Technological Developments in Blood Transfusion Diagnostics
Blood Transfusion Diagnostics are usually deployed during long-hour surgeries, such as kidney transplants, and in cases of emergencies. These surgeries are associated with the chances of excessive blood loss, which makes it difficult to make up for the blood loss with new blood, especially in the case of rare blood groups. Due to the ample demand, key players in the blood transfusion diagnostics market offer advanced and fully automated blood transfusion diagnostics that reduce human interventions. For instance, in April 2019, BD launched its BD BACTEC quality control media to help identify contaminated platelet units during transfusions. Moreover, many companies employed strategic activities, such as acquisitions, partnerships, and other activities, to capture the market. For instance, in December 2019, Getinge purchased Applikon Biotechnology, a leader in the development and supply of innovative bioreactor systems from the laboratory to the industrial scale. In October 2019, Medtronic acquired AV Medical Technologies. Thus, such advancements are likely to bring new trends in the blood transfusion diagnostics market in the coming years.
Market Overview
Brazil is one of the largest countries in SAM. It has a well-established medical device industry regulated by the Brazilian National Health Surveillance Agency (ANVISA). Similarly, the National Institute of Metrology Standardization and Industrial Quality (INMETRO) sets the standards and guidance for companies in the medical device industry in the country. Brazil has the most significant medical equipment industry in the region and is the largest importer of medical devices for the US as it imports ~30% of medical devices from the US. Moreover, sepsis is a severe health issue in Brazil, and this condition requires blood transfusion as a line of treatment. A study published on SciELO from Brazil in 2022 demonstrated that sepsis prevalence is 30% in Brazilian ICUs, while the hospital mortality rate for ICU patients is 55%. Reasons for the significant burden of sepsis include inadequacy of clean water, sanitation, and nutrition; insufficiency of vaccination; low access to intensive care services; and increased incidence of healthcare-associated infections. Therefore, the growing prevalence of sepsis is one of the factors contributing to the blood transfusion diagnostics market growth in Brazil. Furthermore, according to the Brazilian Ministry of Health, 1.9% of the Brazilian population donates blood yearly, accounting for ~4 million blood donations. In Brazil, ~3 million units of blood are collected each year, with the public system accounting for ~70% of donations in these areas. Thus, the abovementioned factors propel the demand for blood transfusion diagnostics in Brazil.
SAM Blood Transfusion Diagnostics Market Segmentation
The SAM blood transfusion diagnostics market is segmented based on product, application, end user, and country.
Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the SAM blood transfusion diagnostics market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 217.55 Million |
| Market Size by 2028 | US$ 302.89 Million |
| CAGR (2022 - 2028) | 5.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| South and Central America | Brazil, Argentina, Rest of South and Central America |
| Market leaders and key company profiles |
|
The South America Blood Transfusion Diagnostics Market is valued at US$ 217.55 Million in 2022, it is projected to reach US$ 302.89 Million by 2028.
As per our report South America Blood Transfusion Diagnostics Market, the market size is valued at US$ 217.55 Million in 2022, projecting it to reach US$ 302.89 Million by 2028. This translates to a CAGR of approximately 5.7% during the forecast period.
The South America Blood Transfusion Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Blood Transfusion Diagnostics Market report:
The South America Blood Transfusion Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Blood Transfusion Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Blood Transfusion Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For South America Blood Transfusion Diagnostics Market
